Bristol-Myers is countering the recent launch of Warner-Lambert's confectionary cholesterol-lowering product Cholybar, which is being promoted as better tasting and more convenient, with a new low calorie product that uses Nutrasweet for a sweetener. The new product, Questran Light, was approved Dec. 5 and will be launched "soon," Bristol-Myers said. The company said that Questran Light will carry a "comparable" price to Questran.
You may also be interested in...
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.